What is CAR-T cell therapy?

In CAR-T cell therapy, the patient’s own T cells (white) are collected, genetically engineered to target cancer cells (pink), and reinjected into the patient. — 123rf.com

Roughly 620,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International’s 2020 report.

Survival rates have improved as advances develop in treatment, such as chimeric antigen receptor-T (CAR-T) cell therapy.